Invention Grant
- Patent Title: Modalities for the treatment of degenerative diseases of the retina
- Patent Title (中): 治疗视网膜退行性疾病的方法
-
Application No.: US13858354Application Date: 2013-04-08
-
Publication No.: US09562217B2Publication Date: 2017-02-07
- Inventor: Irina V. Klimanskaya , Robert Lanza
- Applicant: Advanced Cell Technology, Inc.
- Applicant Address: US MA Marlborough
- Assignee: Astellas Institute for Regenerative Medicine
- Current Assignee: Astellas Institute for Regenerative Medicine
- Current Assignee Address: US MA Marlborough
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K35/12
- IPC: A61K35/12 ; C12N5/079 ; A61K35/44 ; C12N5/0793 ; A61K35/30 ; A61K35/36 ; A61K35/545
Abstract:
This invention relates to methods for improved cell-based therapies for retinal degeneration and for differentiating human embryonic stem cells and human embryo-derived into retinal pigment epithelium (RPE) cells and other retinal progenitor cells.
Public/Granted literature
- US20130302286A1 Modalities for the treatment of degenerative diseases of the retina Public/Granted day:2013-11-14
Information query
